West Palm Beach, Florida – (NewMediaWire) – September 30, 2020 – Ethema Health Corporation (OTCPINK: GRST)
(“Ethema” “GRST” or the “Company”), announces today that its majority owned
subsidiary Evernia Health Center LLC (“Evernia”) has been issued a license from
Florida’s Department of Children and Family Services to operate addiction
treatment services at its location at 950 Evernia Street, West Palm
Beach. The license includes detox, residential, partial hospitalization,
intensive out-patient and out-patient services which allows Evernia to offer a
full continuum of care at its location. Evernia will be doing business as
Addiction Recovery Institute of America (ARIA) and has licensed this name from
another Ethema subsidiary, Addiction Recovery Institute of America LLC.
The website is www.ariafl.com.
The Company’s key personnel are in place and expect to start operating in
the next two to three weeks once all support staff and frontline workers have
been brought on board. As previously announced the Company has been
posting more frequent updates on twitter @healthethema.
last reported on August 20, 2020 on its completion of debt restructuring,
acquisition of Evernia, new financing, SEC filings and other potential
acquisitions. Since then the Company filed its first quarter 10Q and as
previously reported expects the second quarter to be filed shortly. The
accounting for the first and second quarter is a lot more complicated than
normal given the restructuring nature of all the debt amendments and extinguishments
and the accompanying derivative liability treatment of those
transactions. There are extremely large swings in derivative liability
calculation and given the protracted timing of completing all of the
transactions with multiple parties spanning over three quarters, the effective
date of the transactions were in the second quarter and the full effect of the
transactions will be reported in the second quarter filing. We expect
this to make the third quarter statements less complicated and fully expect to
file the third quarter on time.
has received an offer to finance its acquisition of a minority interest in
Biohazard Health Services Ltd. (“Covid clear”) which is conditional on being
current in filings and further due diligence on the acquisition. The ARIA
treatment facility will be certified by Covid Clear for cleanliness and the
ongoing treatment of all of the air and surfaces in the facilities at 950
Evernia Street will ensure the safety and protection of clients and staff at
the facility from potential exposure to viruses.
Ethema Health Corporation
Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space
specifically in the treatment of
substance use disorders. Ethema developed a unique style of treatment over the
last eight years and has had much success with in-patient treatment for adults.
Ethema will continue to develop world class programs and techniques for North
America. For more information you can visit our website at www.ethemahealth.com. Follow us on Twitter
Regarding Forward-Looking Statements
information contained herein includes forward-looking statements. These
statements relate to future events or to our future financial performance, and
involve known and unknown risks, uncertainties and other factors that may cause
our actual results, levels of activity, performance, or achievements to be
materially different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking statements.
You should not place undue reliance on forward-looking statements since
they involve known and unknown risks, uncertainties and other factors which
are, in some cases, beyond our control and which could, and likely will,
materially affect actual results, levels of activity, performance or
achievements. Any forward-looking statement reflects our current views
with respect to future events and is subject to these and other risks,
uncertainties and assumptions relating to our operations, results of
operations, growth strategy and liquidity. We assume no obligation to
publicly update or revise these forward-looking statements for any reason, or
to update the reasons actual results could differ materially from those
anticipated in these forward-looking statements, even if new information becomes
available in the future.
information please contact: